Literature DB >> 1247769

Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.

J Powell-Tuck, J E Lennard-Jones, C S May, C G Wilson, J W Paterson.   

Abstract

A competitive protein-binding assay was used to measure plasma prednisolone levels after administration of prednisolone-21-phosphate retention enemas to seven patients with colitis. Prednisolone appeared in the plasma of all patients after the enema, and concentrations rose to a peak within three hours. In five of the patients plasma prednisolone levels were also measured after the same dose of prednisolone by mouth. Although in individual patients the plasma levels achieved by enema were often quite different from those achieved by mouth, overall the levels achieved by each mode of administration were of a similar order. These findings suggest that 20 mg prednisolone given by retention enema may well exert a systemic effect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247769      PMCID: PMC1638405          DOI: 10.1136/bmj.1.6003.193

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.

Authors:  W A WOOD; G WALTERS; S G FLAVELLMATTS
Journal:  Br Med J       Date:  1964-10-24

2.  Enema volume as an important factor in successful topical corticosteroid treatment of colitis.

Authors:  E T Swarbrick; H Loose; J E Lennard-Jones
Journal:  Proc R Soc Med       Date:  1974-08

3.  Radioimmunoassay for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  Steroids       Date:  1973-06       Impact factor: 2.668

4.  The simultaneous estimation of plasma cortisol and transcortin binding characteristics by a competitive protein binding technique.

Authors:  P J Pegg; P M Keane
Journal:  Steroids       Date:  1969-12       Impact factor: 2.668

  4 in total
  13 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

Authors:  L J O'Donnell; A S Arvind; P Hoang; D Cameron; I C Talbot; D P Jewell; J E Lennard-Jones; M J Farthing
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  A defence of the small clinical trial: evaluation of three gastroenterological studies.

Authors:  J Powell-Tuck; K D MacRae; M J Healy; J E Lennard-Jones; R A Parkins
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

4.  Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam.

Authors:  W S Ruddell; R J Dickinson; M F Dixon; A T Axon
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

5.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

Authors:  J K Marshall; E J Irvine
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

6.  Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.

Authors:  P B McIntyre; F A Macrae; L Berghouse; J English; J E Lennard-Jones
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

7.  Inhibition of leucocyte motility by drugs used in ulcerative colitis.

Authors:  J M Rhodes; T C Bartholomew; D P Jewell
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

8.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

9.  Blood eosinophilia and ulcerative colitis--influence of ethnic origin.

Authors:  G F Benfield; P Asquith
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

10.  Rectally administered prednisolone--evidence for a predominantly local action.

Authors:  D A Lee; M Taylor; V H James; G Walker
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.